STOCK TITAN

The Joint Corp. (JYNT) Form 144 — 12,000 RSU Shares Scheduled for Sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for The Joint Corp. (JYNT) reports a proposed sale of 12,000 shares of common stock via Raymond James on 08/29/2025 with an aggregate market value of $127,920. The filing shows the 12,000 shares were acquired through RSU vesting on multiple dates between 08/07/2021 and 05/25/2024, and that the planned sale equals the total of those vested RSUs. The issuer's outstanding shares are listed as 15,340,000, and the filing also discloses a prior sale by the same person of 20,000 common shares on 08/22/2025 for gross proceeds of $215,000. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Insider plans to sell vested RSUs totaling 12,000 shares (≈$128k); size is immaterial relative to 15.34M shares outstanding.

The transaction documented is the planned sale of 12,000 shares acquired entirely via RSU vesting on dates from 2021 through 2024. At an aggregate value of $127,920, this represents roughly 0.08% of the 15.34 million shares outstanding, indicating the sale is unlikely to be materially dilutive or to significantly affect market supply. The filing also records a recent larger sale of 20,000 shares on 08/22/2025 for $215,000, showing recent insider liquidity activity. Based solely on the filing, there is no disclosed new financial or operational information about the issuer.

TL;DR: Disclosure is routine Rule 144 compliance for vested RSUs; no evidence in this filing of undisclosed material information.

The Form 144 details coordinated sales of shares acquired through RSU vesting and uses a broker (Raymond James). The seller attests to no undisclosed material adverse information, and the filing includes a prior sale in the same month. This appears to be standard insider liquidity activity rather than a governance or disclosure red flag. The filing lacks signatures, filing date, or a named filer CIK in the provided content, which limits verification of procedural completeness from the text supplied.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the JYNT Form 144 report a plan to sell?

The filing reports a proposed sale of 12,000 shares of The Joint Corp. common stock via Raymond James on 08/29/2025 with an aggregate value of $127,920.

How were the 12,000 JYNT shares acquired?

All 12,000 shares were acquired through RSU vesting on various dates between 08/07/2021 and 05/25/2024 as listed in the filing.

What fraction of The Joint Corp.'s outstanding shares does this sale represent?

The filing lists 15,340,000 shares outstanding; 12,000 shares represent approximately 0.08% of that total.

Has the seller sold other JYNT shares recently?

Yes. The filing discloses a prior sale by the same person of 20,000 common shares on 08/22/2025 for gross proceeds of $215,000.

Does the Form 144 state whether undisclosed material information exists?

The person for whose account the securities are to be sold represents by signing the notice that they do not know any material adverse information that has not been publicly disclosed.